Cognition Therapeutics Wraps up FDA Meeting for Zervimesine
10 Jul 2025 //
GLOBENEWSWIRE
Cognition Therapeutics` CT1812 Study Results Accepted For AAIC Presentation
02 Jul 2024 //
GLOBENEWSWIRE
Cognition Completes Enrollment in SHIMMER Phase 2 for DLB
29 Apr 2024 //
GLOBENEWSWIRE